In an experimental melanoma, it was determined that anti-CTLA-4 treatment increased the production of TNFα associated with T lymphocytes infiltration, which in turn upregulated Ezh2, silencing tumor cell immunogenicity and antigen presentation. Here, TNF is linked to neoplasm.